PortfoliosLab logoPortfoliosLab logo
ULBI vs. BKR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ULBI vs. BKR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ultralife Corporation (ULBI) and Baker Hughes Company (BKR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ULBI achieves a 15.03% return, which is significantly lower than BKR's 39.64% return.


ULBI

1D
1.23%
1M
8.40%
YTD
15.03%
6M
14.43%
1Y
-14.99%
3Y*
10.86%
5Y*
-5.76%
10Y*
3.10%

BKR

1D
-0.54%
1M
-1.53%
YTD
39.64%
6M
35.70%
1Y
64.52%
3Y*
30.72%
5Y*
22.39%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ULBI vs. BKR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ULBI
Ultralife Corporation
15.03%-23.22%9.24%76.68%-36.09%-6.65%-12.45%9.48%3.05%-12.08%
BKR
Baker Hughes Company
39.64%13.39%23.11%18.58%25.96%19.03%-15.15%23.01%-30.43%-21.62%

Correlation

The correlation between ULBI and BKR is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Jul 5, 2017

0.16

The correlation between ULBI and BKR shifts across timeframes, from 0.06 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ULBI:

$109.60M

BKR:

$62.89B

EPS

ULBI:

-$0.49

BKR:

$3.14

PS Ratio

ULBI:

0.58

BKR:

2.25

PB Ratio

ULBI:

0.85

BKR:

2.85

Total Revenue (TTM)

ULBI:

$187.86M

BKR:

$27.89B

Gross Profit (TTM)

ULBI:

$43.39M

BKR:

$6.57B

EBITDA (TTM)

ULBI:

$6.73M

BKR:

$4.20B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ULBI vs. BKR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULBI
ULBI Risk / Return Rank: 3131
Overall Rank
ULBI Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
ULBI Sortino Ratio Rank: 3131
Sortino Ratio Rank
ULBI Omega Ratio Rank: 3131
Omega Ratio Rank
ULBI Calmar Ratio Rank: 3131
Calmar Ratio Rank
ULBI Martin Ratio Rank: 3333
Martin Ratio Rank

BKR
BKR Risk / Return Rank: 8888
Overall Rank
BKR Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
BKR Sortino Ratio Rank: 8787
Sortino Ratio Rank
BKR Omega Ratio Rank: 8686
Omega Ratio Rank
BKR Calmar Ratio Rank: 8989
Calmar Ratio Rank
BKR Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULBI vs. BKR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ultralife Corporation (ULBI) and Baker Hughes Company (BKR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ULBIBKRDifference
Sharpe ratioReturn per unit of total volatility

-2.29

Sortino ratioReturn per unit of downside risk

-2.72

Omega ratioGain probability vs. loss probability

1.00

1.34

-0.34

Calmar ratioReturn relative to maximum drawdown

-0.36

3.95

-4.31

Martin ratioReturn relative to average drawdown

-0.58

11.78

-12.36

ULBI vs. BKR - Sharpe Ratio Comparison

The current ULBI Sharpe Ratio is -0.28, which is lower than the BKR Sharpe Ratio of 2.01. The chart below compares the historical Sharpe Ratios of ULBI and BKR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ULBI vs. BKR - Drawdown Comparison

The maximum ULBI drawdown since its inception was -92.90%, which is greater than BKR's maximum drawdown of -75.38%. Use the drawdown chart below to compare losses from any high point for ULBI and BKR.


Loading charts...

Drawdown Indicators


ULBIBKRDifference

Max Drawdown

Largest peak-to-trough decline

-92.90%

-75.38%

-17.52%

Max Drawdown (1Y)

Largest decline over 1 year

-44.69%

-16.86%

-27.83%

Max Drawdown (3Y)

Largest decline over 3 years

-68.83%

-28.00%

-40.83%

Max Drawdown (5Y)

Largest decline over 5 years

-68.83%

-46.53%

-22.30%

Max Drawdown (10Y)

Largest decline over 10 years

-68.83%

Current Drawdown

Current decline from peak

-73.14%

-9.07%

-64.07%

Average Drawdown

Average peak-to-trough decline

-63.48%

-24.66%

-38.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.64%

5.64%

+22.00%

Volatility

ULBI vs. BKR - Volatility Comparison

Ultralife Corporation (ULBI) has a higher volatility of 18.04% compared to Baker Hughes Company (BKR) at 11.29%. This indicates that ULBI's price experiences larger fluctuations and is considered to be riskier than BKR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ULBIBKRDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.04%

11.29%

+6.75%

Volatility (6M)

Calculated over the trailing 6-month period

41.57%

24.84%

+16.73%

Volatility (1Y)

Calculated over the trailing 1-year period

57.63%

33.14%

+24.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

58.99%

35.09%

+23.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.53%

40.20%

+14.33%

Dividends

ULBI vs. BKR - Dividend Comparison

ULBI has not paid dividends to shareholders, while BKR's dividend yield for the trailing twelve months is around 1.46%.


PositionTTM202520242023202220212020201920182017
BKR
Baker Hughes Company
1.46%2.02%2.05%2.28%2.47%2.99%3.45%2.81%3.35%56.42%
ULBI
Ultralife Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ULBI vs. BKR - Financials Comparison

This section allows you to compare key financial metrics between Ultralife Corporation and Baker Hughes Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
47.45M
6.59B
(ULBI) Total Revenue
(BKR) Total Revenue
Values in USD except per share items

ULBI vs. BKR - Profitability Comparison

The chart below illustrates the profitability comparison between Ultralife Corporation and Baker Hughes Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

18.0%20.0%22.0%24.0%26.0%28.0%20222023202420252026
21.3%
22.8%
Portfolio components
ULBI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ultralife Corporation reported a gross profit of 10.11M and revenue of 47.45M. Therefore, the gross margin over that period was 21.3%.

BKR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Baker Hughes Company reported a gross profit of 1.50B and revenue of 6.59B. Therefore, the gross margin over that period was 22.8%.

ULBI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ultralife Corporation reported an operating income of -215.00K and revenue of 47.45M, resulting in an operating margin of -0.5%.

BKR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Baker Hughes Company reported an operating income of 809.00M and revenue of 6.59B, resulting in an operating margin of 12.3%.

ULBI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ultralife Corporation reported a net income of -451.00K and revenue of 47.45M, resulting in a net margin of -1.0%.

BKR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Baker Hughes Company reported a net income of 930.00M and revenue of 6.59B, resulting in a net margin of 14.1%.


Frequently Asked Questions


ULBI and BKR have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ULBI has higher volatility (18.04%) compared to BKR (11.29%). In terms of maximum drawdown, ULBI dropped -92.90% vs BKR's -75.38%.

BKR currently has the higher Sharpe Ratio (2.01 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ULBI and BKR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer